Thomas M. Shiovitz
Thomas M. Shiovitz publishes mostly in Psychiatry and Mental health, Pharmacology and Cardiology and Cardiovascular Medicine, on topics such as Treatment of Major Depression, Dementia and Cognitive Impairment Research and Cholinesterase and Neurodegenerative Diseases.
- World rank
- #1,343,752 of 7,710,434 ranked researchers
- Rank in United States
- #426,133 of 1,627,098
- Works
- 38
- Citations
- 5.2k
- Citations per work
- 137.9
What does Thomas M. Shiovitz research?
Thomas M. Shiovitz's work is mostly in Medicine (46%), Biochemistry, Genetics and Molecular Biology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1948.7%
- Health Sciences1745.7%
- Medicine1745.7%
- Life Sciences25.6%
- 1Psychiatry and Mental health14% of their works
- 2Pharmacology12% of their works
- 3Cardiology and Cardiovascular Medicine8% of their works
- 4Physiology6% of their works
- 5Molecular Biology6% of their works
- 6Public Health, Environmental and Occupational Health6% of their works
Research topics
- Treatment of Major Depression
- Dementia and Cognitive Impairment Research
- Cholinesterase and Neurodegenerative Diseases
- Alzheimer's disease research and treatments
- Schizophrenia research and treatment
- Neurotransmitter Receptor Influence on Behavior
- Cardiac electrophysiology and arrhythmias
- Health Systems, Economic Evaluations, Quality of Life
Which keywords describe Thomas M. Shiovitz's research?
The keywords of their largest research topics: Alzheimer's Disease, Antidepressant, Dementia, Depression, Mild Cognitive Impairment, Acetylcholinesterase, Amyloid Hypothesis and Cholinesterase Inhibitors.
- Quality of Life
- Dopamine
- Arrhythmias
- Antipsychotic Drugs
- Cholinesterase Inhibitors
- Acetylcholinesterase
- Depression
- Antidepressant
- Alzheimer's Disease
- Dementia
- Mild Cognitive Impairment
- Amyloid Hypothesis
- Tau Pathology
- Neurocognitive Deficits
- Cost-effectiveness Analysis
- Long-QT Syndrome
- Serotonin
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Alzheimer's Disease132 topics
- Antidepressant71 topic
- Dementia71 topic
- Depression71 topic
- Mild Cognitive Impairment71 topic
- Acetylcholinesterase61 topic
- Amyloid Hypothesis61 topic
- Cholinesterase Inhibitors61 topic
- Tau Pathology61 topic
- Antipsychotic Drugs41 topic
- Neurocognitive Deficits41 topic
- Arrhythmias31 topic
- Cost-effectiveness Analysis31 topic
- Dopamine31 topic
- Long-QT Syndrome31 topic
- Quality of Life31 topic
- Serotonin31 topic
Where does Thomas M. Shiovitz work?
Thomas M. Shiovitz's main affiliation in the publication record is Los Angeles Clinical Trials, United States.
How many publications and citations does Thomas M. Shiovitz have?
OpenAlex counts 38 works and 5,241 citations for Thomas M. Shiovitz, an h-index of 20, ranking #1,343,752 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Thomas M. Shiovitz. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.